Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Arcutis Biotherapeutics, Inc.
| Metric | Arcutis Biotherapeutics, Inc. ARQTHealthcare |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $372M |
| Net income (latest) | −$16M |
| Operating margin | −3.3% |
| Net margin | −4.3% |
| Return on equity | −8.5% |
| Return on assets | −3.7% |
| Return on capital (ROCE) | −4.0% |
| Debt / equity | 1.29× |
| Revenue growth (YoY) | 123.4% |
| Altman Z″ (distress) | -3.68 |
| Accruals / assets | −2.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.